Trial Number
418-23
Conditions
Leukemia, Lymphoma
Participant Age Range
15 years to 40 years
Participant Gender
Any
Enrolling Participants
Yes
Overview
“A Randomized Trial of Levocarnitine Prophylaxis to Prevent Asparaginase-Associated Hepatotoxicity in Adolescents and Young Adults Receiving Acute Lymphoblastic Leukemia Therapy”
Studying the Effect of Levocarnitine in Protecting the Liver From Chemotherapy for Leukemia or Lymphoma.